Compare Heron Therapeutics Inc (HRTX) vs Stryker Corporation (SYK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Heron Therapeutics Inc vs Stryker Corporation — how do they compare? Heron Therapeutics Inc trades at $0.48 (market cap $91.46M), while Stryker Corporation trades at $314.62 (market cap $122.35B). The key difference: Stryker Corporation is far larger — about 1337.7× Heron Therapeutics Inc's market cap, and Stryker Corporation pays a 1% dividend while Heron Therapeutics Inc pays none. Which is the better fit depends on your goals.
| HRTX | SYK | |
|---|---|---|
Market Cap | $91.46M | $122.35B |
Sector | Health | Technology |
52-Week High | $1.96 | $403.53 |
52-Week Low | $0.39 | $282.58 |
Enterprise Value | $189.36M | $134.10B |
Dividend Yield | — | 1% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Heron Therapeutics Inc
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →About Stryker Corporation
Stryker is a global leader in medical technology, specializing in Orthopaedics, MedSurg, and Neurotechnology. It is renowned for its highly decentralized business model, which empowers 22 specialized business units to drive innovation and category leadership. With its market-leading Mako SmartRobotics™ platform and a relentless M&A strategy, Stryker provides a comprehensive ecosystem of connected surgical tools, implants, and digital solutions that improve both clinical and financial outcomes for hospitals worldwide.
Read more on SYK →
